These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 13913906)

  • 1. [Clinical experience with phenylindanedione].
    SLOER M; BEREZOVSKY M; BERSTEIN S; GNIECKO O; GUIMPEL A
    Dia Med; 1961 Oct; 33():2278-86. PubMed ID: 13913906
    [No Abstract]   [Full Text] [Related]  

  • 2. [Anticoagulant therapy with phenylindanedione. A clinical analysis of 101 cases].
    BUZZI A; FUSTINONI O; CARBAJAL B
    Prensa Med Argent; 1959 Mar; 46():687-92. PubMed ID: 13806585
    [No Abstract]   [Full Text] [Related]  

  • 3. [Therapeutic trial of phenylindanedione ("pindione") in suppository form in hemorrhoids].
    MILSTEIN MJ
    Concours Med; 1960 Mar; 82():1509-12. PubMed ID: 14422695
    [No Abstract]   [Full Text] [Related]  

  • 4. [Phenylindanedione in the treatment of coronary artery disease. A study of its prolonged use in ambulatory patients].
    TANDOWSKY RM
    Sem Med; 1960 Nov; 117():1697-9. PubMed ID: 13775173
    [No Abstract]   [Full Text] [Related]  

  • 5. Heparin resistance, measured by the plasma heparin thrombin time, in patients on long-term anticoagulatn therapy with phenylindanedione following coronary occlusion.
    HOLGER-MADSEN T; SCHIOLER M
    Thromb Diath Haemorrh; 1960 Mar; 4():261-8. PubMed ID: 13848447
    [No Abstract]   [Full Text] [Related]  

  • 6. Heparin resistance determined by the heparin tolerance test in patients treated with phenylindanedione before, during, and after operation.
    GORMSEN J; HAXHOLDT BF
    Acta Chir Scand; 1961; 121():367-76. PubMed ID: 13707283
    [No Abstract]   [Full Text] [Related]  

  • 7. Failure of phenindione to prevent intravascular clotting.
    DUTHIE HL; SMITH G
    Scott Med J; 1960 Jun; 5():265-6. PubMed ID: 13818900
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical experience with phenylindanedione (danilone) with special reference to dosage.
    BEAMISH RE; CARTER SA
    Can Med Assoc J; 1956 Jan; 74(1):39-42. PubMed ID: 13276902
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical experience with anticoagulant danilone (phenylindanedione) in 72 patients.
    PINSKY ST; PIETZ DG; WOOLLING KR; DRAKE WL
    J Indiana State Med Assoc; 1955 Oct; 48(10):1085-94. PubMed ID: 13263636
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical trial of an anti-inflammatory ointment in venous pathology].
    HEYBLON R
    Gaz Med Fr; 1960 Apr; 67():1019-20. PubMed ID: 14401617
    [No Abstract]   [Full Text] [Related]  

  • 11. Thrombelastography and hypercoagulability.
    GORMSEN J
    Acta Med Scand; 1961 Sep; 170():313-8. PubMed ID: 13900565
    [No Abstract]   [Full Text] [Related]  

  • 12. [Uricuric action of 2-phenyl-5-bromo-1, 3-indandione at low dosage].
    MASINI G; LOMBARDI M
    Gazz Med Ital; 1960 Aug; 119():330-3. PubMed ID: 13767770
    [No Abstract]   [Full Text] [Related]  

  • 13. Long term anticoagulant therapy. A six-year study of 43an indandione derivative.
    RAWLS WB; CONNOR CA
    Am J Cardiol; 1959 Oct; 4():470-5. PubMed ID: 14436600
    [No Abstract]   [Full Text] [Related]  

  • 14. A new prothrombopenic drug, phenylindanedione.
    JAQUES LB; GORDON E LEPP E
    Can Med Assoc J; 1950 May; 62(5):465-70. PubMed ID: 15411629
    [No Abstract]   [Full Text] [Related]  

  • 15. Experience with the new anticoagulant phenylindanedione in acute myocardial infarction; preliminary report of 50 cases.
    O'CONNOR WR; THOMPSON CE; BAKER LA
    Q Bull Northwest Univ Med Sch; 1952; 26(3):193-6. PubMed ID: 14957974
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical study of phenylindanedione (danilone) in therapy of thromboembolic diseases].
    MILANES LOPEZ B; HERNANDEZ DIAZ DE ACEVEDO AL; TOLEDO VALDIVIA FB; NAVARRETTE G
    Rev Cubana Cardiol; 1954; 14(3-4):181-94. PubMed ID: 13195101
    [No Abstract]   [Full Text] [Related]  

  • 17. The control of phenylindanedione treatment.
    HEIKINHEIMO R
    Acta Med Scand; 1963 Jun; 173():671-81. PubMed ID: 13953367
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical study of phenylindanedione (danilone) in the treatment of thromboembolic diseases.
    MILANES LOPEZ B; HERNANDEZ AL; TOLEDO VALDIVIA F; NAVARRETE G
    Angiologia; 1954; 6(5):203-16. PubMed ID: 13218328
    [No Abstract]   [Full Text] [Related]  

  • 19. NEW and nonofficial remedies: phenindione.
    J Am Med Assoc; 1953 May; 152(2):142. PubMed ID: 13034553
    [No Abstract]   [Full Text] [Related]  

  • 20. Phenylindanedione: a useful anticoagulant.
    TOWNSEND SR; FAY KJ; DOWNING JR; LAING R; CAMERON DG
    Can Med Assoc J; 1953 Aug; 69(2):149-51. PubMed ID: 13067053
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.